Making Sense of Your Cholangiocarcinoma Journey
You are unique. So is your cancer.
If you or a loved one has been diagnosed with cholangiocarcinoma (CCA), also called bile duct cancer, you probably have a lot of questions. Here, you will find support and information about CCA, testing, and management approaches to help you discuss next steps with your doctor.
Biomarker Testing Discussion Guide
This guide includes questions you may want to ask your oncologist about CCA and biomarker testing—specifically a subtype called molecular profiling—to help you get the conversation started.
Download the Discussion Guide
NCCN Guidelines for Patients®: Gallbladder and Bile Duct Cancers
Learn more about CCA and potential management approaches in this publication from the National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 33 leading cancer centers devoted to patient care, research, and education.
See the NCCN Guidelines for PatientsReferenced with permission from the NCCN Guidelines for Patients® for Gallbladder and Bile Duct Cancers, 2023. © National Comprehensive Cancer Network, Inc. 2023. All rights reserved. Accessed November 6, 2024. To view the most recent and complete version of the NCCN Guidelines for Patients, visit NCCN.org/patientguidelines. NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.